Psychiatric Disorders vs. Maudsley Prescribing Guideline Utilizzo e statistiche

@Point of Care™ Psychiatric Disorders is a clinical decision-making mobile platform. @Point of Care™ Psychiatric Disorders provides a streamlined clinical decision support tool for clinicians to obtain content when it is needed—enabling better decisions, better outcomes, and better care. Featuring @sk with Cognitive AI, clinicians use @Point of Care™ apps to easily access curated, evidence-based, and disease-specific medical content. Clinicians navigate content by asking voice-enabled natural language questions. The @sk with Cognitive AI, confidence-rated answers to efficiently incorporate best treatment options happen more quickly and decisions are made faster to improve patient outcomes at the point of care. @Point of Care™ Psychiatric Disorders is designed to: • Support discovery and practice change • Provide relevant, evidence-based disease-specific medical content • Improve patient outcomes at the point of care Features: • Continually updated Psychiatric content • Topics in diagnosis, treatment, and care management developed with expert physician authors • Case studies, videos, and interviews • Access to actionable patient-recorded data • Detailed reference list with access to original sources • Continuing medical education credit (CME/CE) • Surveys and peer polling • Patient education resources to share with patients
  • App Store di Apple
  • Gratis
  • Settore Medico

Classifica degli store

- -

"Try before you buy" - Download the FREE App, which includes sample content. In-App purchase required to unlock all content. The revised 14th edition of the essential reference for the prescribing of drugs for patients with mental health disorders. Provides succinct coverage of drug treatment of psychiatric conditions and formulating prescribing policy in mental health. The new edition of the world-renowned reference guide on the use of medications for patients presenting with mental health problems? The Maudsley Prescribing Guidelines in Psychiatry is the essential evidence-based handbook on the safe & effective prescribing of psychotropic agents. Covering both common & complex prescribing situations encountered in day-to-day clinical practice, this comprehensive resource provides expert guidance on drug choice, minimum & maximum doses, adverse effects, switching medications, prescribing for special patient groups & more. Each clear & concise chapter includes an up-to-date reference list providing easy access to the evidence on which the guidance is based. The 14th edition has been fully updated to incorporate the latest available research, the most recent psychotropic drug introductions & all psychotropic drugs currently used in the UK, USA, Canada, Australia, New Zealand & Japan. Several new sections cover topics such as deprescribing of major psychiatric drugs, prescribing psychotropics at the end of life, the treatment of agitated delirium, the genetics of clozapine prescribing, the use of weekly penfluridol, and the treatment of psychotropic withdrawal. Featuring contributions by an experienced team of psychiatrists and specialist pharmacists, the new edition of The Maudsley Prescribing Guidelines in Psychiatry: * Provides succinct coverage of drug treatment of psychiatric conditions & formulating prescribing policy in mental health * Covers a wide range of psychiatric conditions including schizophrenia, bipolar disorder, depression & anxiety, borderline personality, eating disorders & many others * Provides advice on prescribing for children & adolescents, older people, pregnant women & other special patient groups * Offers new sections on genetic prescribing, long-acting injectable formulations, ketamine administration and uses & dopamine super-sensitivity * Includes referenced information on off-label prescribing, potential interactions with other substances such as alcohol, tobacco & caffeine, and treating patients with comorbid physical conditions * Whether in the doctor's office, in the clinic, or on the ward, The Maudsley Prescribing Guidelines in Psychiatry, 14th Edition is a must-have for psychiatrists, pharmacists, neuropharmacologists, clinical psychologists, nurses & other healthcare professionals working in mental health, as well as trainees and students in medicine, pharmacy & nursing. Content licensed from printed edition ISBN 10:1119772222 & ISBN 13:9781119772224 SUBSCRIPTION: Please purchase a yearly auto-renewing subscription to receive content access & available updates. Yearly auto-renewing payments- $42.99 Payment will be charged to your iTunes Account at confirmation of purchase. Subscription automatically renews unless auto-renew is turned off at least 24-hours before the end of the current period. Subscription may be managed by the user and auto-renewal can be disabled at any time by going to your device “Settings” and tapping “iTunes & App Store”. Any unused portion of a free trial period will be forfeited when you purchase a subscription, where applicable. If you have any questions or comments, email us any time: customersupport@skyscape.com or call 508-299-3000 Privacy Policy - https://www.skyscape.com/terms-of-service/privacypolicy.aspx Terms and Conditions - https://www.skyscape.com/terms-of-service/licenseagreement.aspx Author(s): David M. Taylor, Thomas R. E. Barnes, Allan H. Young Publisher: John Wiley & Son Inc. and its affiliates
  • App Store di Apple
  • Gratis
  • Settore Medico

Classifica degli store

- -

Psychiatric DisordersRanking a confronto con Maudsley Prescribing Guideline

Confronta la tendenza di classifica Psychiatric Disorders nei ultimi 28 giorni rispetto a Maudsley Prescribing Guideline

Rank

Nessun dato disponibile

Classifica Psychiatric Disorders vs. Maudsley Prescribing Guideline per paese a confronto

Confronta la tendenza di classifica Psychiatric Disorders nei ultimi 28 giorni rispetto a Maudsley Prescribing Guideline

Tutte le categorie

Nessun dato disponibile

Settore Medico

Fai confronti con qualsiasi sito con la nostra prova gratuita

Inizia
Psychiatric Disorders VS.
Maudsley Prescribing Guideline

12icembre d, 2024